CSI Intelligent Financial News Xinhua Pharmaceutical (000756) disclosed its first quarter report for 2024 on April 26.

In the first quarter of 2024, the company achieved total operating income of 2.475 billion yuan, a year-on-year decrease of 6.25%; net profit attributable to the parent company was 142 million yuan, a year-on-year decrease of 6.41%; non-net profit after deduction was 138 million yuan, a year-on-year decrease of 6.41%; Net cash flow was 38.0634 million yuan, compared with -184 million yuan in the same period last year; during the reporting period, Xinhua Pharmaceutical\’s basic earnings per share was 0.21 yuan, and the weighted average return on net assets was 3.04%.

In the first quarter of 2024, the company\’s gross profit margin was 27.44%, a year-on-year decrease of 3.94 percentage points; the net profit margin was 5.87%, an increase of 0.04 percentage points from the same period last year.

Data shows that the company\’s weighted average return on net assets in the first quarter of 2024 was 3.04%, a decrease of 0.55 percentage points from the same period last year; the company\’s return on invested capital in the first quarter of 2024 was 2.42%, a decrease of 0.35 percentage points from the same period last year. .

In the first quarter of 2024, the company\’s net cash flow from operating activities was 38.0634 million yuan, a year-on-year increase of 222 million yuan; the net cash flow from financing activities was 16.7888 million yuan, a year-on-year increase of 73.2062 million yuan; the net cash flow from investing activities was -52.4753 million yuan , it was -55.7406 million yuan in the same period last year.

In the first quarter of 2024, the company\’s operating income cash ratio was 82.39% and the net cash ratio was 26.83%.

In terms of major changes in assets, as of the end of the first quarter of 2024, the company\’s accounts receivable increased by 51.40% from the end of the previous year, and the proportion of the company\’s total assets increased by 4.06 percentage points; inventory decreased by 13.70% from the end of the previous year, and the proportion of the company\’s total assets decreased by 2.47 percentage points. percentage points; fixed assets decreased by 2.61% from the end of the previous year, and the proportion of the company\’s total assets decreased by 1.89 percentage points; construction in progress increased by 13.41% from the end of the previous year, and the proportion of the company\’s total assets increased by 0.96 percentage points.

In terms of major changes in liabilities, as of the end of the first quarter of 2024, the company\’s other payables (including interest and dividends) increased by 26.61% from the end of the previous year, accounting for an increase of 1.25 percentage points in the company\’s total assets; contract liabilities decreased by 41.64% from the end of the previous year, accounting for the company\’s total assets The proportion of total assets decreased by 0.77 percentage points; employee compensation payable decreased by 26.38% from the end of the previous year, and the proportion of the company\’s total assets decreased by 0.42 percentage points; short-term borrowings decreased by 10.40% from the end of the previous year, and the proportion of the company\’s total assets decreased by 0.43 percentage points.

The first quarter report shows that among the company\’s top ten tradable shareholders at the end of the first quarter of 2024, the new shareholders are Southern CSI 1000 Traded Open Index Securities Investment Fund, Guotai Junan Quantitative Stock Selection Hybrid Initiated Securities Investment Fund, Lu Yonghong, and Shenwan Hongyuan Securities Co., Ltd., replacing Galaxy De Rui Capital Management Co., Ltd., Vanguard Growth Preferred Flexible Allocation Hybrid Securities Investment Fund, He Zhonglin and Wang Xiangpei at the end of last year.

In terms of specific shareholding ratios, the shareholdings of Hong Kong Securities Clearing Company Limited and Hu Kui have increased, while the shareholdings of Hualu Holdings Group Co., Ltd., Hong Kong Securities Clearing Company (Agents) Co., Ltd., Yu Haitao, and Guo Fengying have decreased.